ClinicalTrials.Veeva

Menu

Effects of L-arginine and L-citrulline Supplementation on Muscle Respiration

L

Loughborough University

Status

Completed

Conditions

Dietary Exposure

Treatments

Dietary Supplement: Dietary Supplement
Behavioral: Endurance exercise on a cycle ergometer

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT03998800
R19-P010

Details and patient eligibility

About

The objective of this trial is to determine the effects of dietary supplementation with the amino acids, L-arginine and L-citrulline, on endurance performance and mitochondrial respiration in healthy men compared to supplementation with L-arginine alone and a placebo supplement.

Full description

This study is a randomized, double-blind, cross over trial of L-arginine and L-citrulline supplementation, L-arginine supplementation alone and placebo supplementation in healthy men. The intervention period will be 8-11 weeks for each participant and a minimum of 15 individuals will be recruited and enrolled to complete the trial. Subjects will complete the experimental protocol described below over 3 individual 10 day supplementation periods, separated by washout periods of approximately 2 weeks. Subjects will ingest corn-starch as a placebo, L-arginine (3g/day) or L-arginine (1.5 g/day) + L-citrulline (1.5g/day). On day 7 of the supplementation period, a skeletal muscle biopsy and blood sample will be obtained from the subjects to investigate mitochondrial function and blood amino acid and nitric oxide levels. On day 10 of the supplementation period, subjects will complete a performance test on a cycle ergometer to investigate their endurance performance. These assessments will be performed to determine the effects of co-ingesting L-arginine and L-citrulline compared to L-arginine alone and placebo administration.

Enrollment

18 patients

Sex

Male

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • healthy male, 18-40 years of age
  • recreationally-active
  • healthy BMI (≥18.5 and ≤24.9 kg/m2)

Exclusion criteria

  • participating in other studies currently or in the past two months or has an intention to participate in other studies over the period of this study
  • history of gastric, digestive, cardiovascular, renal disease or any other orthopaedic diseases related to motor organs
  • lidocaine allergy
  • use of medication that may affect study measures
  • contraindication to the biopsy procedures
  • on medications that affect the immune system
  • on Aspirin or other drugs known to prolong bleeding
  • smoker
  • user of dietary supplements currently or in the past one month
  • a heavy drinker

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

18 participants in 3 patient groups, including a placebo group

L-arginine and L-citrulline
Experimental group
Description:
10 days of supplementation with 1.5 g of L-arginine and 1.5 g of L-citrulline per day
Treatment:
Behavioral: Endurance exercise on a cycle ergometer
Dietary Supplement: Dietary Supplement
L-arginine
Experimental group
Description:
10 days of supplementation with 3 g of L-arginine per day
Treatment:
Behavioral: Endurance exercise on a cycle ergometer
Dietary Supplement: Dietary Supplement
Placebo (corn-starch)
Placebo Comparator group
Description:
10 days of supplementation with corn-starch
Treatment:
Behavioral: Endurance exercise on a cycle ergometer
Dietary Supplement: Dietary Supplement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems